Results 231 to 240 of about 53,608 (389)

An Improved QIM-JPEG2000 Steganography and Its Evaluation by Steganalysis

, 2009
Takayuki Ishida, Kazumi Yamawaki, Hideki Noda, Michiharu Niimi   +3 more
openalex   +2 more sources

Circulating tumor DNA monitoring and blood tumor mutational burden in patients with metastatic solid tumors treated with atezolizumab

Molecular Oncology, EarlyView.
In patients treated with atezolizumab as a part of the MyPathway (NCT02091141) trial, pre‐treatment ctDNA tumor fraction at high levels was associated with poor outcomes (radiographic response, progression‐free survival, and overall survival) but better sensitivity for blood tumor mutational burden (bTMB).
Charles Swanton, Russell W. Madison, Candice Francheska B. Tambaoan, Funda Meric‐Bernstam, Christopher J. Sweeney, Razelle Kurzrock, Howard A. Burris III, David R. Spigel, Hanna Tukachinsky, Jason Hughes, Julia Malato, Bongin Yoo, Tania Szado, Cheryl Schwab, Lincoln W. Pasquina, Amaya Gasco, Katja Schulze, Claire F. Friedman   +17 more
wiley   +1 more source

A deep learning-driven multi-layered steganographic approach for enhanced data security. [PDF]

Sci Rep
Sanjalawe Y, Al-E'mari S, Fraihat S, Abualhaj M, Alzubi E.   +4 more
europepmc   +1 more source

ContSteg: Contourlet-Based Steganography Method

, 2009
Hedieh Sajedi, Mansour Jamzad
openalex   +2 more sources

Minimizing additive distortion functions with non-binary embedding operation in steganography [PDF]

, 2010
Tomáš Filler, Jessica Fridrich
openalex   +1 more source

Genomics‐led approach to drug testing in models of undifferentiated pleomorphic sarcoma

Molecular Oncology, EarlyView.
GA text Genomic data from undifferentiated pleomorphic sarcoma patients and preclinical models were used to inform a targeted drug screen. Selected compounds were tested in 2D and 3D cultures of UPS cell lines. A combination of trametinib and infigratinib was synergistic in the majority of UPS cell lines tested, which was further confirmed in an ex ...
Piotr J. Manasterski, Molly R. Danks, John P. Thomson, Morwenna Muir, Martin Lee, John C. Dawson, Ana T. Amaral, Juan Diaz‐Martin, David S. Moura, Javier Martin‐Broto, Ali Alsaadi, Donald M. Salter, Ailsa J. Oswald, Graeme Grimes, Larry Hayward, Ted R. Hupp, Karen Sisley, Paul H. Huang, Neil O. Carragher, Valerie G. Brunton   +19 more
wiley   +1 more source

AGASI: A Generative Adversarial Network-Based Approach to Strengthening Adversarial Image Steganography. [PDF]

Entropy (Basel)
Fan H, Jin C, Li M.
europepmc   +1 more source

The subcellular distribution of phosphorylated Y‐box‐binding protein‐1 at S102 in colorectal cancer patients, stratified by KRAS mutational status and clinicopathological features

Molecular Oncology, EarlyView.
This study identifies nuclear YB‐1 S102 phosphorylation as a marker associated with KRAS and FBXW7 mutations in colorectal cancer. Mutated KRAS correlates specifically with nuclear, not cytoplasmic, S102 YB‐1. These findings provide the first ex vivo evidence of this link in CRC and suggest future studies should assess the prognostic and therapeutic ...
Konstanze Lettau, Stephan Forchhammer, Birgit Fehrenbacher, Lejla Mahmutovic, Marcus Scharpf, Gunnar Blumenstock, Martin Schaller, Irina Bonzheim, Shayan Khozooei, Mahmoud Toulany   +9 more
wiley   +1 more source

MFI-Net: multi-level feature invertible network image concealment technique. [PDF]

PeerJ Comput Sci
Cheng D, Zhu M, Yang B, Gao X, Jing W, Mao Y, Zhao F.   +6 more
europepmc   +1 more source

MRF Based LSB Steganalysis: A New Measure of Steganography Capacity

, 2009
Debasis Mazumdar, Apurba Das, Sankar K. Pal   +2 more
openalex   +1 more source